Autres langues Anatara Lifesciences Ltd

Actions

ANR

AU000000ANR0

Temps Différé Australian S.E. Autres places de cotation 01:59:59 06/05/2024			Varia. 5j.	Varia. 1 janv.
0,048 ^AUD	0,00%		-2,04%	+118,18%

01/05	Anatara Lifesciences lève 1 million de dollars australiens par le biais d'un placement d'actions ; les actions baissent de 6%.	MT
09/04	Anatara Lifesciences commence à recruter des patients pour la deuxième phase de l'essai sur le syndrome du côlon irritable	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	01/05
Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	09/04
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Anatara Lifesciences Raised Nealy AU$960,000 Via Entitlement Offer	08/12
Anatara Lifesciences Limited Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Ltd Announces Board Changes	01/10/23
Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial	28/09/23
Anatara Lifesciences Finalizes Patients for Irritable Bowel Syndrome Clinical Trial Stage One	31/08/23
Anatara Lifesciences Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23
Anatara Lifesciences Receives R&D Tax Rebate; Shares Up 3%	14/08/23
Anatara Lifesciences Ltd Announces Registered Office Change	20/04/23
Anatara Lifesciences Provides Update on the Gastrointestinal Reprogramming(Garp) Trial for IBS	09/03/23
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
Anatara Lifesciences Ltd Announces board Changes	06/12/22
Anatara Lifesciences Raising Funds for Patient Trial, Future Project Acquisitions	21/10/22
Anatara Lifesciences Receives More than $310,000 R&D Tax Rebate	05/10/22
CSIRO Halts Psychological Functioning Trial for Dietary Supplement	03/10/22
Anatara Lifesciences Limited Provides Updates on 3FDC Clinical Trial	02/10/22
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	29/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Anatara Lifesciences Ltd

Actions

ANR

AU000000ANR0

Autres langues

Filtres